Don't want ads? Subscribe or login now.

Amgen Hid IRS' $10B Tax Dispute, Shareholder Suit Alleges

By Katryna Perera · March 14, 2023, 11:25 PM EDT

Biotech company Amgen Inc. was hit with a securities class action alleging the company hid years of reports, adjustments and deficiency notices from the Internal Revenue Service, which led to artificially inflated...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Roofers Local No. 149 Pension Fund v. Amgen Inc. et al

Case Number

1:23-cv-02138

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

March 13, 2023

Recent Articles By Katryna

December 21, 2023
ABA Tax Tells IRS To Narrow Digital Asset Reg Definitions
October 20, 2023
Tax Tipster Brings Award Bid In $60M Case To High Court
August 25, 2023
Colo. Accounting Firm CFO Sues For Control Of Business
August 21, 2023
Calif. Taxpayers Say Card Co. Botched Refund Distribution
July 19, 2023
Ex-SEC Officials Tell 5th Circ. To Vacate SEC Buyback Rule
May 01, 2023
SEC Inks $1.3M Deal With Ex-Official In Stanford Ponzi Scam
December 05, 2022
FTX's Auditors Face Class Action Over Crypto Co.'s Collapse
October 18, 2022
PCAOB Boots Accounting Firm, Hits Auditor With Record Fine
July 25, 2022
Bank Wants Cannabis Co.'s Early Win Bid Nipped In The Bud
May 19, 2022
Judge Cuts 'Unreasonable' Atty Fee Bid In $98M Mattel Deal